Vir Biotechnology closes Sanofi licence deal for T-cell engagers
Vir Biotechnology has concluded an exclusive worldwide licence agreement with Sanofi, enabling access to multiple clinical-stage T-cell engagers (TCEs) and…
Vir Biotechnology has concluded an exclusive worldwide licence agreement with Sanofi, enabling access to multiple clinical-stage T-cell engagers (TCEs) and…
Epsilogen has completed a Series B expansion financing round, raising £12.5m ($16.4m) to progress the development of its immunoglobulin E…
The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Abdera Therapeutics’ ABD-147, a treatment aimed…
ArsenalBio has closed an oversubscribed Series C financing round, securing $325m to propel its programmable cell therapy programmes through clinical…
Merck & Co has received European Commission (EC) approval for the use of Keytruda (pembrolizumab) along with Padcev (enfortumab vedotin-ejfv)…
Jacobio Pharma has out-licensed the China rights of its assets, glecirasib and JAB-3312, to Shanghai Allist Pharmaceuticals. Glecirasib is a…
ImCheck Therapeutics has received €20.18m ($22.35m) in non-dilutive funding from the French government to advance its pipeline. The funds were…
The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Nuvectis Pharma’s NXP800, targeting AT-rich interactive…
Repare Therapeutics plans to reduce its workforce by around 25% as the company prioritises operations on its four clinical programmes…
TC BioPharm (TCBP) has announced the receipt of a patent grant from the European Patent Office covering modified gamma delta…